Risk factors for early disseminated intravascular coagulation in neonates with sepsis

WANG Wen-Hua; XU Ding; HAN Ya-Mei; YANG Zi-Jiu

doi:10.7499/j.issn.1008-8830.2015.04.010

PDF(1224 KB)

Chinese Journal of Contemporary Pediatrics ›› 2015, Vol. 17 ›› Issue (4) : 341-344. DOI: 10.7499/j.issn.1008-8830.2015.04.010

CLINICAL RESEARCH

Risk factors for early disseminated intravascular coagulation in neonates with sepsis

WANG Wen-Hua, XU Ding, HAN Ya-Mei, YANG Zi-Jiu

Author information +

History +

Abstract

Objective To investigate the risk factors for early disseminated intravascular coagulation (DIC) in neonates with sepsis. Methods A retrospective clinical study was performed on 100 neonates with a confirmed diagnosis of sepsis between 2012 and 2013. The children were classified into normal coagulation group, non-overt DIC group (early DIC group), and overt DIC group (late DIC group) based on the ISTH overt DIC scoring system. The clinical manifestations and risk factors were analyzed statistically. Results Early DIC occurred in 44 (44%) cases in the 100 neonates with sepsis. The incidence of sclerema showed significant differences between the three groups (P<0.05). Asphyxia, bleeding, and Gram-negative bacterial infection were independent risk factors for early DIC. Conclusions Coagulation function should be actively monitored and early intervention measures should be taken for neonates with asphyxia, bleeding, and Gram-negative bacterial infection to prevent early DIC from progressing to late DIC.

Key words

Sepsis / Disseminated intravascular coagulation / Neonate

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations

WANG Wen-Hua, XU Ding, HAN Ya-Mei, YANG Zi-Jiu. Risk factors for early disseminated intravascular coagulation in neonates with sepsis[J]. Chinese Journal of Contemporary Pediatrics. 2015, 17(4): 341-344 https://doi.org/10.7499/j.issn.1008-8830.2015.04.010

References

[1] Edmond K, Zaidi A. New approaches to preventing, diagnosing, and treating neonatal sepsis[J]. Plos Medicine, 2010, 7(3): 1-8.
[2] Volante E, Moretti S, Pisani F, et al. Early diagnosis of bacterial infection in the neonate[J]. J Matern Fetal Neonatal Med, 2004, 16(2): 13-16.
[3] 何颜霞. 脓毒症凝血功能紊乱与抗凝治疗进展[J]. 中国实用儿科杂志, 2011, 26(12): 914-916.
[4] 乔凤伶, 冷平. 弥散性血管内凝血诊断标准研究进展[J]. 成都医学院学报, 2010, 5(4): 342-346.
[5] 许靖, 潘新年. 新生儿弥漫性血管内凝血特征及诊断方法的进展[J]. 中华儿科杂志, 2013, 51(3): 227-230.
[6] 苏磊, 彭娜, 唐丽群. 脓毒症时弥漫性血管内凝血的发病机制与临床进展[J]. 中华急诊医学杂志, 2012, 21(4): 345-350.
[7] 中华医学会儿科学分会新生儿学组, 《中华医学会中华儿科杂志》编辑委员会. 新生儿败血症诊疗方案[J]. 中华儿科杂志, 2003, 41(12): 897-899.
[8] 刘敏涓, 刘泽霖. 关于DIC 的定义、临床、实验室标准与其计分系统[J]. 血栓与止血学, 2002, 8(2): 85-86.
[9] 赵捷, 庄思齐. 新生儿早期凝血分子标志物检测的临床意义[J]. 国际儿科学杂志, 2006, 33(1): 58-60.
[10] 郝玲, 王娜. 败血症新生儿血栓调节蛋白和D- 二聚体的变化及意义[J]. 中国当代儿科杂志, 2013, 15(10): 841-844.
[11] Oren H, Cingoz I, Duman M, et al. Disseminated intravascular coagulation in pediatric patients: clinical and laboratory features and prognostic factors influencing the survival[J]. Pediatr Hematol Oncol, 2005, 22(8): 679-688.
[12] 孟哲, 李文益, 陈环, 等. 小儿弥散性血管内43 例临床分析[J]. 中国当代儿科杂志, 2002, 4(3): 1008-8830.
[13] 王政力, 余加林. 新生儿败血症诊断新进展[J]. 中国当代儿科杂志, 2013, 15(3): 236-240.
[14] Camacho-Gonzalez A, Spearman PW, Stoll BJ. Neonatal infectious diseases: evaluation of neonatal sepsis[J]. Pediatr Clin North Am, 2013, 60(2): 367-389.
[15] Pichler E, Pichler L. The neonatal coagulation system and the vitamin K deficiency bleeding-a mini review[J]. Wien Med Wochenschr, 2008, 158(13-14): 385-395.
[16] 杨璐, 李秋平, 许靖, 等. 不同胎龄新生儿凝血功能的临床研究[J]. 国际检验医学杂志, 2013, 34(16): 2078-2082.
[17] Strunk T, Currie A, Richmond P, et al. Innate immunity in human newborn infants: prematurity means more than immaturity[J]. J Matern Fetal Neonatal Med, 2011, 24(1): 25-31.
[18] Bauman ME, Cheung PY, Massicotte MP. Hemostasis and platelet dysfunction in asphyxiated neonates[J]. J Pediatr, 2011, 158(2 Suppl): e35-e39.
[19] 郭铭玉, 郭杰, 高丽, 等. 新生儿硬肿症出凝血功能的变化及其临床意义[J]. 中国实用儿科杂志, 2000, 15(2): 95-96.
[20] Levi M, van der Poll T. The role of natural anticoagulants in the pathogenesis and management of systemic activation of coagulation and inflammation in critically ill patients[J]. Semin Thromb Hemost, 2008, 34(5): 459-468.
[21] Zeckey C, Andruszkow H, Neunaber C, et al. Protective effects of finasteride on the pulmonary immune response in a combined model of trauma-hemorrhage and polymicrobial sepsis in mice[J]. Cytokine, 2011, 56(2): 305-311.
[22] Schroeder JE, Weiss YG, Mosheiff R. The current state in the evaluation and treatment of ARDS and SIRS[J]. Injury, 2009, 40(Suppl 4): S82-S89.